Literature DB >> 15221564

Infrainguinal bypass surgery for chronic arterial occlusive disease associated with essential thrombocythemia: report of a case.

Takaki Sugimoto1, Takashi Kitade, Takeshi Mimura, Takashi Koyama, Takeshi Hatta, Sigeru Kurisu, Kazuya Kodama, Shingo Wakatsuki.   

Abstract

A 63-year-old man was referred to our hospital with a 3-year history of intermittent claudication, and his angiogram showed a total occlusion of the bilateral infrainguinal arteries. In addition, based on a platelet count of 172 x 10(4)/mm(3) as well as the characteristic bone marrow findings, he was diagnosed to have essential thrombocythemia. After the platelet count and aggregation response improved on administration of ranimustine and antiplatelet agents, infrainguinal bypass surgery was performed using the saphenous vein and prosthetic grafts. The bilateral grafts had been patent for 10 months postoperatively, but his discontinuance of medication caused an acute occlusion of the prosthetic graft. The graft was salvaged with a prompt thrombectomy and, now under strict medication control, he is leading an active life.

Entities:  

Mesh:

Year:  2004        PMID: 15221564     DOI: 10.1007/s00595-004-2759-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  2 in total

Review 1.  Abdominal surgery in patients with essential thrombocythemia: A case report and systematic review of literature.

Authors:  Yi Zhu; HongGang Jiang; ZhiHeng Chen; BoHao Lu; JiaMing Wu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

2.  Thrombotic Lesions are Associated with Poor Outcomes after Endovascular Treatment in Patients with Non-Acute Aortoiliac Total Occlusions.

Authors:  Yoshito Kadoya; Kan Zen; Osamu Iida; Yoshito Yamamoto; Daizo Kawasaki; Yasutaka Yamauchi; Yoshiaki Shintani; Teruyasu Sugano; Hiroyoshi Yokoi; Satoaki Matoba; Masato Nakamura
Journal:  J Atheroscler Thromb       Date:  2021-02-10       Impact factor: 4.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.